You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent Wilms tumor and other childhood kidney tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

Recruiting
  • Wilms Tumor
  • +6 more
  • Los Angeles, California
  • +10 more
Aug 2, 2023

Childhood Choroid Plexus Tumor, Childhood Medulloblastoma, Childhood Pineoblastoma Trial in Detroit (filgrastim)

Terminated
Has Results
  • Childhood Choroid Plexus Tumor
  • +10 more
  • filgrastim
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Oct 2, 2020

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

    Recruiting
    • Colorectal Carcinoma
    • +21 more
    • Dual X-ray Absorptiometry
    • +2 more
    • Birmingham, Alabama
    • +18 more
    Jan 30, 2023

    Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

    Terminated
    • Lymphoma
    • +15 more
    • Charlottesville, Virginia
      University of Virginia
    Feb 8, 2022

    Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)

    Recruiting
    • Brain Tumor, Recurrent
    • +3 more
    • Houston, Texas
      Texas Children's Cancer Center
    Aug 15, 2022

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

      Recruiting
      • Malignant Solid Neoplasm
      • +40 more
      • Biospecimen Collection
      • +6 more
      • Birmingham, Alabama
      • +172 more
      Jan 27, 2023

      Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

      Recruiting
      • Brain Tumor
      • +2 more
      • Atlanta, Georgia
        Children's Healthcare of Atlanta (CHOA)
      Jul 24, 2022

      Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Malignant Rhabdoid Tumor Trial in Australia, New Zealand, United States

      Terminated
      • Rhabdoid Tumor
      • +3 more
      • Durham, North Carolina
      • +10 more
      Jun 5, 2022

      Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

      Active, not recruiting
      • Advanced Solid Tumors
      • +15 more
      • (no location specified)
      Sep 16, 2022

      Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)

      Recruiting
      • Atypical Teratoid/Rhabdoid Tumor
      • +17 more
      • Atezolizumab
      • +7 more
      • Birmingham, Alabama
      • +19 more
      Feb 2, 2023

      Adult Solid Tumor Trial in Canada, Germany, United States (SQZ-PBMC-HPV, Atezolizumab, Ipilimumab)

      Active, not recruiting
      • Adult Solid Tumor
      • SQZ-PBMC-HPV
      • +3 more
      • Scottsdale, Arizona
      • +12 more
      Jan 17, 2023

      Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

      Recruiting
      • Melanoma
      • Solid Tumor
      • Los Angeles, California
      • +13 more
      Jul 27, 2022

      Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

      Active, not recruiting
      • Malignant Rhabdoid Tumors (MRT)
      • +10 more
      • San Francisco, California
      • +31 more
      Jan 17, 2023